Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | OTHER |
| Centre de Validació ClÃnica de Solucions Digitals | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Chronic Obstructive Pulmonary Disease (COPD), characterized by persistent airflow limitation in the respiratory airways, is a chronic condition that affects millions of people worldwide. ReHub enables healthcare professionals to design therapeutic exercise programs for the treatment of COPD patients, as well as to analyze and monitor patient rehabilitation through the information and feedback provided via the platform. The main objective of the study is to evaluate the satisfaction and usability of the ReHub platform (for respiratory rehabilitation) among COPD patients and healthcare professionals. This is a single-center satisfaction and usability study on the usage and experience of the ReHub platform (for respiratory rehabilitation).
Chronic Obstructive Pulmonary Disease (COPD), characterized by persistent airflow limitation in the respiratory airways, is a chronic condition that affects millions of people worldwide. According to various studies, COPD is one of the leading causes of morbidity and mortality in Spain and the third leading cause of death globally. Research conducted in Spain on a representative sample of the population indicates that the overall prevalence of COPD in Spain is approximately 10.2% among adults aged 40 and older. However, significant regional differences are observed, with higher rates in the northern and northeastern regions of the country.
ReHub allows healthcare professionals to design therapeutic exercise programs for the treatment of COPD patients and to analyze and monitor patient rehabilitation through the information and feedback provided via the platform.
The main objective of the study is to assess the satisfaction and usability of the ReHub platform (for respiratory rehabilitation) among COPD patients and healthcare professionals.
Methology:
Single-center satisfaction and usability study on the usage and experience of the ReHub platform (for respiratory rehabilitation). Additionally, changes in clinical parameters and functional status will be evaluated at the end of the study compared to the baseline situation (pre-post intervention study without a control group).
Recruitment will take place at the Respiratory Rehabilitation Service of Hospital Sant Pau (Barcelona-Spain). A consecutive sampling of patients who meet the inclusion criteria will be conducted during the recruitment period or until the sample size of 100 participants is reached. Participants who meet the inclusion criteria and none of the exclusion criteria will be invited to participate in the study. Once their acceptance to participate is obtained, they will be included in the study and will receive training on how to use the ReHub platform.
After using the platform for a minimum of 4 months, a survey will be administered to the patients to assess their satisfaction and usability. Additionally, changes in clinical parameters and the functional status of the patients will be assessed at the end of the study compared to the baseline situation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ReHub | Experimental | ReHub is a medical device designed to assist rehabilitation professionals by providing information for the design, monitoring, and analysis of therapeutic exercise programs for respiratory functional rehabilitation. Patients use the platform to follow the exercise program designed by their therapist from the location that suits them best. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ReHub | Device | ReHub provides support to rehabilitation professionals by offering information for the design, monitoring, and analysis of therapeutic exercise programs for respiratory functional rehabilitation. |
| Measure | Description | Time Frame |
|---|---|---|
| System Usability Scale (SUS) | User satisfaction and experience (Spanish version), from 0 to 100; higher score means a better outcome | 4 months |
| Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Patients | Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications for patients, from 0 to 100; higher score means a better outcome | 4 months |
| Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Healthcare Professionals | Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications for Healthcare professionals, from 0 to 100; higher score means a better outcome | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Walking test_dysnea | Dyspnea level (pre and post) assessed by Borg Scale (number from 0 none to 10 maximum) | Baseline and 4 months |
| Walking test_fatigue | Fatigue level (pre and post) assessed by Borg Scale (number from 0 none to 10 maximum) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Carme Puy, MD | Contact | +34935565972 | mpuyr@santpau.cat |
| Name | Affiliation | Role |
|---|---|---|
| Carme Puy, MD | Pneumologist at Hospital Santa Creu i Sant Pau | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital de la Santa Creu i Sant Pau | Recruiting | Barcelona | 08041 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
ReHub is a medical device designed to assist rehabilitation professionals by providing information for the design, monitoring, and analysis of therapeutic exercise programs for respiratory functional rehabilitation. Patients use the platform to follow the exercise program designed by their therapist from the location that suits them best.
Not provided
Not provided
Not provided
Not provided
| Baseline and 4 months |
| Walking test_oxygen | SaO2 (oxygen saturation) (pre and post) in percent | Baseline and 4 months |
| Walking test_ heart rate | Heart rate (pre and post) in beats per minute (bpm) | Baseline and 4 months |
| Walking test_distance | Distance walked in meters | Baseline and 4 months |
| Walking test_stops | Number of stops (integer number) | Baseline and 4 months |
| Walking test_stops duration | Stops duration in minutes | Baseline and 4 months |
| Adverse events during exercise | Adverse events during exercise: dyspnea (shortness of breath) | During the exercises |
| Adherence to the platform_frequency | Compliance with the rehabilitation program in terms of frequency of use (number of days connected to the platform) | 4 months |
| Adherence to the platform_compliance | Compliance with the rehabilitation program in terms of percent of performed exercices versus prescribed exercices | 4 months |
| Adherence to the platform_connection time | Compliance with the rehabilitation program in terms of connection time (in minutes) | 4 months |
| Interaction between the physiotherapist and the patient | Number of messages exchanged between the patient and the physiotherapist through ReHub platform | During the follow-up until 4 months |
| Chronic Obstructive Pulmonary Disease (COPD) Assessment scale (CAT) | Quality of life COPD patients scale; from 0 to 40; higher score means a worse outcome | Baseline and 4 months |
| modified Medical Research Council scale (mMRC) | Dyspnea scale; from 0 to 4; higher score means a worse outcome | Baseline and 4 months |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |